The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments ...
After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...
Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...
“Companies should really sit down and say, could I meet these points?” Hogan Lovells partner Lynn Mehler said. “How do I follow the larger concept at play here, which is FDA willingness to be ...
The FDA has proposed new guidelines to facilitate the approval of customized treatments for rare diseases, aiming to address ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results